Effects of C/EBPα and C/EBPβ in BCR/ABL-expressing cells: Differences and similarities

Cell Cycle

Volumn 5, Issue 12, 2006, Pages 1254-1257

  Guerzoni, Clara ^a   Ferrari Amorotti, Giovanna ^b   Bardini, Michela ^b   Mariani, Samanta A ^a   Calabretta, Bruno ^b  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

Cell cycle; Differentiation; Leukemia; Transcription factor; Tumor suppressor gene

Indexed keywords

BCR ABL PROTEIN; CCAAT ENHANCER BINDING PROTEIN ALPHA; CCAAT ENHANCER BINDING PROTEIN BETA; IMATINIB; MESSENGER RNA; RETINOIC ACID; DNA BINDING PROTEIN; LAMINA ASSOCIATED POLYPEPTIDE 2; LAMINA-ASSOCIATED POLYPEPTIDE 2; MEMBRANE PROTEIN;

5' UNTRANSLATED REGION; BINDING SITE; BLAST CELL CRISIS; CELL CYCLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CHRONIC MYELOID LEUKEMIA; DRUG EFFECT; LEUKEMIA CELL; LEUKEMOGENESIS; MYELOID PROGENITOR CELL; NONHUMAN; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; REVIEW; ANIMAL; ARTICLE; COMPARATIVE STUDY; GENE EXPRESSION; GENETICS; HUMAN; METABOLISM;

ANIMALS; CCAAT-ENHANCER-BINDING PROTEIN-ALPHA; CCAAT-ENHANCER-BINDING PROTEIN-BETA; DNA-BINDING PROTEINS; FUSION PROTEINS, BCR-ABL; GENE EXPRESSION; HUMANS; MEMBRANE PROTEINS;

EID: 33745157578     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.5.12.2808     Document Type: Review

References (37)

1. Ramji DP, Foka P. CCAAT/enhancer -binding proteins: Structure, function and regulation. Biochem J 2002; 365:561-75.
2. Zhang DE, Zhang P, Wang ND, Hetherington CJ, Darlington GJ, Tenen DJ. Absence of granulocyte colony-stimulating factor signaling and neutrophil development in CCAAT enhancer binding protein alpha-deficient mice. Proc Natl Acad Sci USA 1997; 94:569-74.
3. Zhang P, Iwasaki-Arai J, Iwasaki H, Fenyus ML, Dayaram T, Owens BM, Shigematsu H, Levantini E, Huettner CS, Lekstrom-Kimes JA, Akashi K, Tenen DG. Enhancement of hematopoietic stem cell repopulating capacity and self-renewal in the absence of the transcription factor C/EBP alpha. Immunity 2004; 21:853-63.
4. Screpanti I, Romani L, Musiani P, Modesti A, Fattori E, Lazzaro D, Sellitto C, Scarpa S, Bellavia D, Lattanzio G, Bistoni F, Frati L, Cortese R, Gulino A, Ciliberto G, Costantini F, Poli V. Lymphoproliferative disorder and unbalanced T-helper response in C/EBPβ-deficient mice. EMBO J 1995; 14:1932-1941.
5. Tanaka T, Akira S, Yoshida K, Umemoto M, Yoneda Y, Shirafuji N, Fujiwara H, Suematsu S, Yoshida N, Kishimoto T. Targeted disruption of the NF-IL6 gene discloses its essential role in bacteria killing and tumor cytotoxicity by macrophages. Cell 1995; 80:353-62.
6. Jones LC, Lin ML, Chen SS, Krug V, Hofman WK, Lee S, Lee XH, Koeffler HP. Expression of C/EBPβ from the C/EBPα gene locus is sufficient for normal hematopoiesis in vivo. Blood 2002; 99:2032-6.
7. Lekstrom-Himes JA, Dorman SE, Kopar P, Holland SM, Gallin JI. Neutrophil-specific granule deficiency results from a novel mutation with loss of function of the transcription factor CCAAT/enhancer binding protein epsilon. J Exp Med 1999; 189:1847-52.
8. Gombart AF, Shiohara M, Kwok SH, Agematsu K, Komiyama A, Koeffler HP. Neutrophil-specific granule deficiency: Homozygous recessive inheritance of a frameshift mutation in the gene encoding transcription factor CCAAT/enhancer binding protein-epsilon. Blood 2001; 97:2561-7.
9. Yamanaka R, Barlow C, Lekstrom-Himes J, Castilla LH, Liu PP, Eckhaus M, Decker T, Wynshaw-Boris A. Impaired granulopoiesis, myelodysplasia, and early lethality in CCAAT/enhancer binding protein e-deficient mice. Proc Natl Acad Sci USA 1997; 94:13187-92.
10. Tenen DG. Disruption of differentiation in human cancer: AML shows the way. Nat Rev Cancer 2003; 3:89-101.
11. Pabst T, Mueller BU, Zhang P, Radomska HS, Narravula S, Schnittger S, Behre G, Hiddemann W, Tenen DG. Dominant-negative mutations of CEBPA, encoding CCAAT/enhancer binding protein-alpha (C/EBPalpha), in acute myeloid leukemia. Nat Genet 2001; 27:263-70.
12. Gombart AF, Hofmann WK, Kawano S, Takeuchi S, Krug U, Kwok SH, Larsen RJ, Asou H, Miller CW, Hoelzer D, et al. Mutations in the gene encoding the transcription factor CCAAT/enhancer binding protein alpha in myelodysplastic syndromes and acute myeloid leukemias. Blood 2002; 99:1332-40.
13. Pabst T, Mueller BU, Harakawa N, Schoch C, Haferlach T, Behre G, Hiddemann W, Zhang DE, Tenen DG. AML1-ETO downregulates the granulocytic differentiation factor C/EBPalpha in t(8;21) myeloid leukemia. Nat Med 2001; 7:444-51.
14. Zheng R, Friedman AD, Levis M, Li L, Weir EG, Small D. Internal tandem duplication mutation of FLT3 blocks myeloid differentiation through suppression of C/EBPα expression. Blood 2004; 103:1883-90.
15. Radomska HS, Bassères DS, Zheng R, Zhang P, Dayaram T, Yamamoto Y, Sternberg DW, Lokker N, Giese NA, Bohlander SK, Schnittger S, Delmotte MH, Davis RJ, Small D, Hiddemann W, Gilliland DG, Tenen DG. Block of C/EBPα function by phosphorylation in acute myeloid leukemia with FLT3 activating mutations. J Exp Med 2006; In press.
16. Perrotti D, Cesi V, Trotta R, Guerzoni C, Santilli G, Campbell K, Iervolino A, Condorelli F, Gambacorti-Passerini C, Caligiuri MA, Calabretta B. BCR-ABL suppresses C/EBPalpha expression through inhibitory action of hnRNP E2. Nat Genet 2002; 30:48-58.
17. Tavor S, Park DJ, Gery S, Vuong PT, Gombart AF, Koeffler HP. Restoration of C/EBPalpha expression in a BCR-ABL+ cell line induces terminal granulocytic differentiation. J Biol Chem 2003; 278:52651-9.
18. Guerzoni C, Bardini M, Mariani SA, Ferrari-Amorotti G, Neviani P, Panno ML, Zhang Y, Martinez R, Perrotti D, Calabretta D. Inducible activation of C/EBPβ, a gene negatively regulated by BCR/ABL, inhibits proliferation and promotes differentiation of BCR/ABL-expressing cells. Blood 2006; In press.
19. Descombes P, Schibler V. A liver-enriched transcriptional activator protein, LAP, and a transcriptional inhibitory protein, LIP, are translated from the same mRNA. Cell 1991; 67:569-79.
20. Calkhoven CF, Muller C, Leutz A. Translational control of C/EBPα and C/EBPβ isoforms expression. Genes and Dev 2000; 14:1920-32.
21. Eaton EM, Hanlon M, Bundy L, Sealy L. Characterization of C/EBPβ isoforms in normal versus neoplastic mammary epithelial cells. J Cell Physiol 2001; 189:91-105.
22. Zahnow CA, Cardiff RD, Laucirica R, Medina D, Rosen JM. A role for CCAAT/enhancer binding protein beta - Liver enriched inhibitory protein in mammary epithelial cell proliferation. Cancer Res 2001; 61:261-9.
23. Leudde T, Duderstadt M, Streetz KL, Tacke F, Kubieka S, Manns MP, Trautwein C. C/EBPβ isoforms LIP and LAP modulate progression of the cell cycle in the regenerating mouse liver. Hepatology 2004; 40:356-65.
24. Zhang JW, Tang RR, Vinson C, Lane MD. Dominant-negative C/EBP disrupts mitotic clonal expansion and differentiation of 3T3-L1 preadipocytes. Proc Natl Acad Sci USA 2004; 101:43-7.
25. Duprez E. A new role for C/EBPbeta in acute promyelocytic leukemia. Cell Cycle 2004; 3:389-90.
26. Schuster C, Forster K, Dierks H, Elsässer A, Behre G, Simon H, Danhauser-Riedl S, Hallek M, Warmuth M. The effect of BCR/ABL on C/EBP transcription factor regulation and neutrophilic differentiation are reversed by the Abl Kinase inhibitor imatinib mesylate. Blood 2003; 101:655-63.
27. Ferrari-Amorotti G, Keeshan K, Zattoni M, Guerzoni C, Cattelani S, Donato NJ, Calabretta B. Leukemogenesis induced by wild type and STI571-resistant BCR/ABL is potently suppressed by C/EBPα. Blood 2006; In press.
28. Wang H, Iakova P, Wilde M, Welm A, Goode T, Roesler WJ, Timchenko NA. C/EBPalpha arrests cell proliferation through direct inhibition of Cdk2 and Cdk4. Mol Cell 2001; 8:817-28.
29. Porse BT, Pedersen T, Xu X, Lindberg B, Wewer UM, Friis-Hansen L, Nerlov C. E2F repression by C/EBPα is required for adipogenesis and granulopoiesis in vivo. Cell 2001; 107:247-58.
30. Muller C, Calkhoven CF, Sha X, Leutz A. The CCAAT enhancer-binding protein alpha (C/EBPalpha) requires a SWI/SNF complex for proliferation arrest. J Biol Chem 2004; 279:7353-8.
31. Keeshan K, Santilli G, Corradini F, Pernotti D, Calabretta B. The transcription activation function of C/EBPα is required for induction of granulocytic differentiation. Blood 2003; 102:1267-75.
32. Williams SC, Baer M, Dillner AJ, Johnson PF. CRP2 (C/EBPβ) contains a bipartite regulatory domain that controls transcriptional activation, DNA binding and cell specificity. EMBO J 1995; 14:3170-83.
33. Zhu S, Yoon K, Sterneck E, Johnson PF, Smart RC. CCAAT/enhancer binding protein-beta is a mediator of keratinocyte survival and skin tumorigenesis involving oncogenic Ras signaling. Proc Natl Acad Sci USA 2002; 99:207-12.
34. Hollander MC, Sheikh MS, Bulavin DV, Lundgren K, Augeri-Henmueller L, Shehee R, Molinaro TA, Kim KE, Tolosa E, Ashwell JD, Rosenberg MP, Zhan Q, Fernandez-Salguero PM, Morgan WF, Deng CX, Fornace Jr AJ. Genomic instability in Gadd45 a-deficient mice. Nat Genet 1999; 23:176-84.
35. Sheikh MS, Hollander MC, Fornace Jr AJ. Role of Gadd45 in apoptosis. Biochem Pharmacol 2000; 59:43-5.
36. Wang XW, Zhan Q, Coursen JD, Khan MA, Kortny HU, Yu L, Hollander MC, O'Connor PM, Fornace Jr AJ, Harris CC. GADD45 induction of a G2/M cell cycle checkpoint. Proc Natl Acad Sci USA 1999; 96:3706-11.
37. Duprez E. A new role for C/EBPbeta in acute promyelocytic leukemia. Cell Cycle 2004; 3:389-90.